ARCHIVES

In Senate testimony, NCI director uses survival rate as measure of progress for goal to “eliminate suffering and death due to cancer.”

This article is from The Cancer Letter archive.

Vol. 31 No. 30 | July 29, 2005

Download PDF Visit The Full Archive

Related Articles

Trials Approved by NCI CTEP Last Month

November 25, 2011

Natural Substance Blocks Androgen Activity In Vitro

April 27, 2001

FDA approves Irinotecan, Days After ODAC Meeting

June 21, 1996

Survival Of Control Programs After NCI Money Runs Out Developing Into A Worrisome Issue

June 1, 1975

NCI Hits Grant Targets, But Labs Feel The Pain Of Budget Cuts, Director Says.

November 23, 2007

Alcohol Consumption Increases Risk Of Lobular And HR+ Breast Cancer

August 27, 2010